Literature DB >> 28559404

Peripheral T-Cell Reactivity to Heat Shock Protein 70 and Its Cofactor GrpE from Tropheryma whipplei Is Reduced in Patients with Classical Whipple's Disease.

Lucia Trotta1,2, Kathleen Weigt2, Katina Schinnerling2, Anika Geelhaar-Karsch2, Gerrit Oelkers2, Federico Biagi1, Gino Roberto Corazza1, Kristina Allers2, Thomas Schneider2, Ulrike Erben2, Verena Moos3.   

Abstract

Classical Whipple's disease (CWD) is characterized by the lack of specific Th1 response toward Tropheryma whipplei in genetically predisposed individuals. The cofactor GrpE of heat shock protein 70 (Hsp70) from T. whipplei was previously identified as a B-cell antigen. We tested the capacity of Hsp70 and GrpE to elicit specific proinflammatory T-cell responses. Peripheral mononuclear cells from CWD patients and healthy donors were stimulated with T. whipplei lysate or recombinant GrpE or Hsp70 before levels of CD40L, CD69, perforin, granzyme B, CD107a, and gamma interferon (IFN-γ) were determined in T cells by flow cytometry. Upon stimulation with total bacterial lysate or recombinant GrpE or Hsp70 of T. whipplei, the proportions of activated effector CD4+ T cells, determined as CD40L+ IFN-γ+, were significantly lower in patients with CWD than in healthy controls; CD8+ T cells of untreated CWD patients revealed an enhanced activation toward unspecific stimulation and T. whipplei-specific degranulation, although CD69+ IFN-γ+ CD8+ T cells were reduced upon stimulation with T. whipplei lysate and recombinant T. whipplei-derived proteins. Hsp70 and its cofactor GrpE are immunogenic in healthy individuals, eliciting effective responses against T. whipplei to control bacterial spreading. The lack of specific T-cell responses against these T. whipplei-derived proteins may contribute to the pathogenesis of CWD.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  T-cell immunity; Tropheryma whipplei; Whipple's disease; cofactor GrpE; heat-shock protein 70

Mesh:

Substances:

Year:  2017        PMID: 28559404      PMCID: PMC5520441          DOI: 10.1128/IAI.00363-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Genome-based design of a cell-free culture medium for Tropheryma whipplei.

Authors:  Patricia Renesto; Nicolas Crapoulet; Hiroyuki Ogata; Bernard La Scola; Guy Vestris; Jean-Michel Claverie; Didier Raoult
Journal:  Lancet       Date:  2003-08-09       Impact factor: 79.321

2.  Direct access to CD4+ T cells specific for defined antigens according to CD154 expression.

Authors:  Marco Frentsch; Olga Arbach; Dennis Kirchhoff; Beate Moewes; Margitta Worm; Martin Rothe; Alexander Scheffold; Andreas Thiel
Journal:  Nat Med       Date:  2005-09-25       Impact factor: 53.440

3.  Whipple disease: intestinal infiltrating cells exhibit a transcriptional pattern of M2/alternatively activated macrophages.

Authors:  Benoît Desnues; Hubert Lepidi; Didier Raoult; Jean-Louis Mege
Journal:  J Infect Dis       Date:  2005-09-30       Impact factor: 5.226

4.  Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease.

Authors:  Jean-Christophe Lagier; Florence Fenollar; Hubert Lepidi; Didier Raoult
Journal:  J Antimicrob Chemother       Date:  2011-03-08       Impact factor: 5.790

5.  B-cell epitopes of antigenic proteins in Leishmania infantum: an in silico analysis.

Authors:  L M Assis; J R Sousa; N F S Pinto; A A Silva; A F M Vaz; P P Andrade; E M Carvalho; M A De Melo
Journal:  Parasite Immunol       Date:  2014-07       Impact factor: 2.280

6.  Intervening sequence acquired by lateral gene transfer in Tropheryma whipplei results in 23S rRNA fragmentation.

Authors:  Nicolas Crapoulet; Sylvianne Robineau; Didier Raoult; Patricia Renesto
Journal:  Appl Environ Microbiol       Date:  2005-11       Impact factor: 4.792

7.  Architectural and functional alterations of the small intestinal mucosa in classical Whipple's disease.

Authors:  H-J Epple; J Friebel; V Moos; H Troeger; S M Krug; K Allers; K Schinnerling; A Fromm; B Siegmund; M Fromm; J D Schulzke; T Schneider
Journal:  Mucosal Immunol       Date:  2017-02-08       Impact factor: 7.313

8.  Looking for Tropheryma whipplei source and reservoir in rural Senegal.

Authors:  Alpha Kabinet Keita; Oleg Mediannikov; Pavel Ratmanov; Georges Diatta; Hubert Bassene; Clémentine Roucher; Adama Tall; Cheikh Sokhna; Jean-François Trape; Didier Raoult; Florence Fenollar
Journal:  Am J Trop Med Hyg       Date:  2012-12-18       Impact factor: 2.345

9.  A paradoxical Tropheryma whipplei western blot differentiates patients with whipple disease from asymptomatic carriers.

Authors:  Florence Fenollar; Bernard Amphoux; Didier Raoult
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

10.  Recombinant complexes of antigen with stress proteins are potent CD8 T-cell-stimulating immunogens.

Authors:  Andreas Wieland; Markus Denzel; Erika Schmidt; Stefan Kochanek; Florian Kreppel; Jörg Reimann; Reinhold Schirmbeck
Journal:  J Mol Med (Berl)       Date:  2008-06-13       Impact factor: 4.599

View more
  2 in total

1.  Epidemiology of Whipple's Disease in the USA Between 2012 and 2017: A Population-Based National Study.

Authors:  Jamie Ann Elchert; Emad Mansoor; Mohannad Abou-Saleh; Gregory S Cooper
Journal:  Dig Dis Sci       Date:  2018-11-28       Impact factor: 3.199

2.  Human galectin-1 and galectin-3 promote Tropheryma whipplei infection.

Authors:  Diyoly Ayona; Sandra Madariaga Zarza; Ludovic Landemarre; Benoît Roubinet; Philippe Decloquement; Didier Raoult; Pierre-Edouard Fournier; Benoit Desnues
Journal:  Gut Microbes       Date:  2021 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.